PureTech Health plc
NASDAQ: PRTC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert William Henry Lyne
- Employees
- 56
- Headquarters
- Boston, United States
- IPO year
- 2020
- Market cap
- $424.1M
- Website
- https://puretechhealth.com
Loading PRTC…
Loading profile data…Frequently asked questions about PRTC
What does PureTech Health plc (PRTC) do?
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded...
Where does PRTC trade?
PureTech Health plc (PRTC) trades on the NASDAQ.
What sector is PRTC in?
PureTech Health plc (PRTC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PureTech Health plc?
Robert William Henry Lyne is the chief executive officer of PureTech Health plc (PRTC).
Where is PureTech Health plc headquartered?
PureTech Health plc is headquartered in United States.
Does PRTC pay a dividend?
PureTech Health plc (PRTC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRTC go public?
PureTech Health plc (PRTC) completed its initial public offering in 2020.